Neoadjuvant chemotherapy with docetaxel-cisplatin in patients with stage III N2 non-small-cell lung cancer

scientific article published on 04 January 2013

Neoadjuvant chemotherapy with docetaxel-cisplatin in patients with stage III N2 non-small-cell lung cancer is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.CLLC.2012.10.003
P698PubMed publication ID23291258

P50authorJames Chih-Hsin YangQ37840097
Chong-Jen YuQ42255080
Chao-Chi HoQ57009805
Wei-Yu LiaoQ57020031
Jin-Yuan ShihQ63654593
P2093author name stringMuzo Wu
Jin-Hsin Chen
Kuan-Yuh Chen
P433issue4
P304page(s)418-424
P577publication date2013-01-04
P1433published inClinical Lung CancerQ332299
P1476titleNeoadjuvant chemotherapy with docetaxel-cisplatin in patients with stage III N2 non-small-cell lung cancer
P478volume14

Reverse relations

cites work (P2860)
Q37624187Evaluation of Safety and Efficacy of Salvage Therapy With Sunitinib, Docetaxel (Tyxan) and Cisplatinum Followed by Maintenance Vinorelbine for Unresectable/Metastatic Nonsmall Cell Lung Cancer: Stage 1 of a Simon 2 Stage Clinical Trial. [Corrected].
Q39020392New basic approach to treat non-small cell lung cancer based on RNA-interference
Q90026052Pathologic Assessment After Neoadjuvant Chemotherapy for NSCLC: Importance and Implications of Distinguishing Adenocarcinoma From Squamous Cell Carcinoma
Q36525431Pathological response after neoadjuvant chemotherapy in resectable non-small-cell lung cancers: proposal for the use of major pathological response as a surrogate endpoint
Q90346695Prognostic significance of pathological complete response in non-small cell lung cancer following neoadjuvant treatment
Q34420618Tumor-associated macrophages in stage IIIA pN2 non-small cell lung cancer after neoadjuvant chemotherapy and surgery

Search more.